Literature DB >> 30933775

Dissecting hiPSC-CM pacemaker function in a cardiac organoid model.

Mirja L Schulze1, Marc D Lemoine2, Alexander W Fischer3, Katharina Scherschel4, Robert David5, Kristoffer Riecken6, Arne Hansen1, Thomas Eschenhagen1, Bärbel M Ulmer7.   

Abstract

Biological pacemakers could be a promising alternative to electronic pacemakers and human induced pluripotent stem cell derived cardiomyocytes (hiPSC-CM) may represent a suitable source for implantable cells. To further unravel this potential a thorough understanding of pacemaker function with regard to coupling processes both in the physiological and in the graft-host context is required. Here we developed a 2-component cardiac organoid model with a hiPSC-CM embryoid body (EB) as trigger casted into a rat engineered heart tissue (EHT) as arrhythmic beating substrate. Contractility recordings revealed that the EB controlled the beating activity of the EHT, leading to a regular hiPSC-CM-like beating pattern instead of the irregular beating typically seen in rat EHT. Connectivity was observed with action potential (AP) measurements and calcium transients transmitting from the EB directly into the rat EHT. Immunohistochemistry and genetically labeled hiPSC-CMs demonstrated that EB-derived and rat cells intermingled and formed a transitional zone. Connexin 43 expression followed the same pattern as histological and computer models have indicated for the human sinoatrial node. In conclusion, hiPSC-CM EBs function as a biological pacemaker in a 2-component cardiac organoid model, which provides the possibility to study electrophysiological and structural coupling mechanisms underlying propagation of pacemaker activity.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  3D cell culture model; Biological pacemaker function; Coupling; Engineered heart tissue; Human induced pluripotent stem cells; Transitional zone

Year:  2019        PMID: 30933775     DOI: 10.1016/j.biomaterials.2019.03.023

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  6 in total

Review 1.  Workshop Report: FDA Workshop on Improving Cardiotoxicity Assessment With Human-Relevant Platforms.

Authors:  Li Pang; Philip Sager; Xi Yang; Hong Shi; Frederick Sannajust; Mathew Brock; Joseph C Wu; Najah Abi-Gerges; Beverly Lyn-Cook; Brian R Berridge; Norman Stockbridge
Journal:  Circ Res       Date:  2019-10-10       Impact factor: 17.367

Review 2.  A potential ex vivo infection model of human induced pluripotent stem cell-3D organoids beyond coronavirus disease 2019.

Authors:  Hang Zhou; Li-Ping Liu; Mei Fang; Yu-Mei Li; Yun-Wen Zheng
Journal:  Histol Histopathol       Date:  2020-04-27       Impact factor: 2.303

Review 3.  Enhancing Matured Stem-Cardiac Cell Generation and Transplantation: A Novel Strategy for Heart Failure Therapy.

Authors:  Ampadu O Jackson; Ganiyu A Rahman; Kai Yin; Shiyin Long
Journal:  J Cardiovasc Transl Res       Date:  2020-11-30       Impact factor: 4.132

Review 4.  From engineered heart tissue to cardiac organoid.

Authors:  Jaeyeaon Cho; Hyein Lee; Woongchan Rah; Hyuk Jae Chang; Young-Sup Yoon
Journal:  Theranostics       Date:  2022-03-14       Impact factor: 11.600

5.  A three-dimensional culture system for generating cardiac spheroids composed of cardiomyocytes, endothelial cells, smooth-muscle cells, and cardiac fibroblasts derived from human induced-pluripotent stem cells.

Authors:  Asher Kahn-Krell; Danielle Pretorius; Bijay Guragain; Xi Lou; Yuhua Wei; Jianhua Zhang; Aijun Qiao; Yuji Nakada; Timothy J Kamp; Lei Ye; Jianyi Zhang
Journal:  Front Bioeng Biotechnol       Date:  2022-07-22

6.  Case Report on: Very Early Afterdepolarizations in HiPSC-Cardiomyocytes-An Artifact by Big Conductance Calcium Activated Potassium Current (Ibk,Ca).

Authors:  András Horváth; Torsten Christ; Jussi T Koivumäki; Maksymilian Prondzynski; Antonia T L Zech; Michael Spohn; Umber Saleem; Ingra Mannhardt; Bärbel Ulmer; Evaldas Girdauskas; Christian Meyer; Arne Hansen; Thomas Eschenhagen; Marc D Lemoine
Journal:  Cells       Date:  2020-01-20       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.